Filed: 5/7/2026ACC: 0001193125-26-212011
📋 What this filing means
TRV GP IV, LLC filed this quarterly 13F‑HR report disclosing 2 equity positions with a total reported market value of $266.90M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
2
Positions
$266.90M
Total AUM (reported)
10.85M
Total Shares
Allocation by class
COM$266.90M100.0%
Portfolio Concentration
Top 3$266.90M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 10.85M
Sole
Full voting authority
10.85M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole2
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings2
Rows:
MAZE THERAPEUTICS, INC.
SOLEShares4.47M
TypeSH
Market value$133.55M
50.04%
Sole
4.47M
Shared
0.00
None
0.00
TANGO THERAPEUTICS, INC.
SOLEShares6.37M
TypeSH
Market value$133.36M
49.96%
Sole
6.37M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
MAZE THERAPEUTICS, INC.SOLE | COM | 4.47M | SH | $133.55M 50.04% | 4.47M | 0.00 | 0.00 |
TANGO THERAPEUTICS, INC.SOLE | COM | 6.37M | SH | $133.36M 49.96% | 6.37M | 0.00 | 0.00 |